JP2025163128A5 - - Google Patents
Info
- Publication number
- JP2025163128A5 JP2025163128A5 JP2025128256A JP2025128256A JP2025163128A5 JP 2025163128 A5 JP2025163128 A5 JP 2025163128A5 JP 2025128256 A JP2025128256 A JP 2025128256A JP 2025128256 A JP2025128256 A JP 2025128256A JP 2025163128 A5 JP2025163128 A5 JP 2025163128A5
- Authority
- JP
- Japan
- Prior art keywords
- branched
- substituted
- unsubstituted
- straight
- reducing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962847348P | 2019-05-14 | 2019-05-14 | |
| PCT/IL2020/050524 WO2020230134A1 (en) | 2019-05-14 | 2020-05-14 | Acss2 inhibitors and methods of use thereof |
| ILPCT/IL2020/050524 | 2020-05-14 | ||
| JP2022568774A JP7723011B2 (ja) | 2019-05-14 | 2021-05-12 | イミダゾール3-オキシド誘導体系acss2阻害剤及びその使用方法 |
| PCT/IL2021/050541 WO2021229571A1 (en) | 2019-05-14 | 2021-05-12 | Imidazole 3-oxide derivative based acss2 inhibitors and methods of use thereof |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022568774A Division JP7723011B2 (ja) | 2019-05-14 | 2021-05-12 | イミダゾール3-オキシド誘導体系acss2阻害剤及びその使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2025163128A JP2025163128A (ja) | 2025-10-28 |
| JP2025163128A5 true JP2025163128A5 (cg-RX-API-DMAC7.html) | 2025-11-06 |
| JP7904373B2 JP7904373B2 (ja) | 2026-08-12 |
Family
ID=73288933
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021567836A Pending JP2022532718A (ja) | 2019-05-14 | 2020-05-14 | Acss2阻害剤およびその使用方法 |
| JP2021567839A Pending JP2022532719A (ja) | 2019-05-14 | 2020-05-14 | Acss2阻害剤およびその使用方法 |
| JP2022568774A Active JP7723011B2 (ja) | 2019-05-14 | 2021-05-12 | イミダゾール3-オキシド誘導体系acss2阻害剤及びその使用方法 |
| JP2025128256A Active JP7904373B2 (ja) | 2019-05-14 | 2025-07-31 | イミダゾール3-オキシド誘導体系acss2阻害剤及びその使用方法 |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021567836A Pending JP2022532718A (ja) | 2019-05-14 | 2020-05-14 | Acss2阻害剤およびその使用方法 |
| JP2021567839A Pending JP2022532719A (ja) | 2019-05-14 | 2020-05-14 | Acss2阻害剤およびその使用方法 |
| JP2022568774A Active JP7723011B2 (ja) | 2019-05-14 | 2021-05-12 | イミダゾール3-オキシド誘導体系acss2阻害剤及びその使用方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US12441689B2 (cg-RX-API-DMAC7.html) |
| EP (3) | EP3983386A4 (cg-RX-API-DMAC7.html) |
| JP (4) | JP2022532718A (cg-RX-API-DMAC7.html) |
| KR (3) | KR20220024014A (cg-RX-API-DMAC7.html) |
| CN (3) | CN114008025A (cg-RX-API-DMAC7.html) |
| AU (3) | AU2020273727A1 (cg-RX-API-DMAC7.html) |
| BR (2) | BR112021022977A2 (cg-RX-API-DMAC7.html) |
| CA (3) | CA3136083A1 (cg-RX-API-DMAC7.html) |
| IL (3) | IL297883A (cg-RX-API-DMAC7.html) |
| MX (3) | MX2021013786A (cg-RX-API-DMAC7.html) |
| SG (2) | SG11202112277PA (cg-RX-API-DMAC7.html) |
| WO (3) | WO2020230134A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12133852B2 (en) | 2017-11-15 | 2024-11-05 | Epivario, Inc. | ACSS2 inhibitors and methods of use thereof |
| US11795160B2 (en) | 2019-02-22 | 2023-10-24 | Insilico Medicine Ip Limited | Kinase inhibitors |
| EP3983386A4 (en) * | 2019-05-14 | 2023-01-11 | Metabomed Ltd | ACSS2 INHIBITORS AND METHODS OF USE THEREOF |
| PH12022551379A1 (en) | 2019-12-06 | 2023-05-03 | Vertex Pharma | Substituted tetrahydrofurans as modulators of sodium channels |
| CN112480085B (zh) * | 2020-12-17 | 2022-10-25 | 上海英诺富成生物科技有限公司 | 一种化合物或其药学上可接受的盐、异构体、前药、多晶型物或溶剂化物 |
| AU2022225035A1 (en) | 2021-02-24 | 2023-08-31 | Insilico Medicine Ip Limited | Analogs for the treatment of disease |
| SI4347031T1 (sl) | 2021-06-04 | 2026-01-30 | Vertex Pharmaceuticals Incorporated | N-(hidroksialkil (hetero)aril) tetrahidrofuran karboksamidi kot modulatorji natrijevih kanalčkov |
| CN114044754A (zh) * | 2021-11-23 | 2022-02-15 | 贵州大学 | 一类5-三氟甲基-4-吡唑衍生物的制备方法及其在抑制肿瘤细胞上的应用 |
| CN114716380B (zh) * | 2022-04-01 | 2024-06-21 | 新乡医学院 | 一种相转移催化的4-取代吡唑酮类化合物不对称氟化方法 |
| US20260137687A1 (en) * | 2022-08-24 | 2026-05-21 | The Regents Of The University Of California | GTPase INHIBITORS AND USES THEREOF |
| CN116808042A (zh) * | 2023-08-08 | 2023-09-29 | 江苏省人民医院(南京医科大学第一附属医院) | 乙酰辅酶a合成酶2抑制剂在治疗胰腺神经内分泌肿瘤中的应用 |
| CN118344267A (zh) * | 2024-04-17 | 2024-07-16 | 广东广康生化科技股份有限公司 | 一种联苯肼酯高效合成新方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE140966C (cg-RX-API-DMAC7.html) | ||||
| DE2324893A1 (de) | 1973-05-17 | 1974-12-12 | Hoechst Ag | 1-hydroxy-imidazole und verfahren zu ihrer herstellung |
| US3905997A (en) | 1974-06-21 | 1975-09-16 | Warner Lambert Co | 3-Aryl-5-oxo-2-pyrazoline-4-carboxanilides and process therefor |
| US4207317A (en) | 1978-03-13 | 1980-06-10 | Ciba-Geigy Corporation | 1-Aryl-4-carbamoyl-pyrazolin-5-ones |
| DD140966A1 (de) * | 1978-12-28 | 1980-04-09 | Doerthe Creuzburg | Mittel zur regulierung des pflanzenwachstums |
| JPH11291635A (ja) | 1998-04-06 | 1999-10-26 | Mitsubishi Paper Mills Ltd | 感熱記録材料 |
| DE69926148D1 (en) * | 1998-11-09 | 2005-08-18 | Black James Foundation | Gastrin und cholecystokinin rezeptor ligande |
| AR034897A1 (es) | 2001-08-07 | 2004-03-24 | Hoffmann La Roche | Derivados n-monoacilados de o-fenilendiaminas, sus analogos heterociclicos de seis miembros y su uso como agentes farmaceuticos |
| CA2465978C (en) * | 2001-09-14 | 2015-04-07 | Soon Hyung Woo | Inhibitors of histone deacetylase |
| JP4988591B2 (ja) * | 2004-12-17 | 2012-08-01 | イーライ リリー アンド カンパニー | 新規なmch受容体アンタゴニスト |
| WO2007026215A1 (en) * | 2005-08-29 | 2007-03-08 | Glenmark Pharmaceuticals S.A. | Pyrazole derivatives as cannabinoid receptor ligands, pharmaceutical compositions containing? them, and processes for their preparation |
| JP2013526540A (ja) * | 2010-05-12 | 2013-06-24 | バーテックス ファーマシューティカルズ インコーポレイテッド | Atrキナーゼ阻害剤として有用な化合物 |
| US9073911B2 (en) * | 2011-06-09 | 2015-07-07 | Hoffmann-La Roche Inc. | Pyrazole derivatives |
| AU2012355624A1 (en) * | 2011-12-23 | 2014-07-17 | Novartis Ag | Compounds for inhibiting the interaction of BCL2 with binding partners |
| WO2013159224A1 (en) | 2012-04-25 | 2013-10-31 | University Of Manitoba | 2-carbamo(thio)yl-1,3- dioxopropyl derivatives in cancer therapy |
| WO2015175845A1 (en) | 2014-05-15 | 2015-11-19 | Peloton Therapeutics, Inc. | Benzimidazole derivatives and uses thereof |
| ES2995198T3 (en) | 2016-01-05 | 2025-02-07 | Incyte Corp | Pyridine compounds as pi3k-gamma inhibitors |
| WO2019036562A1 (en) * | 2017-08-18 | 2019-02-21 | Saint Louis University | ERR INVERSE AGONISTS |
| CN111629787A (zh) * | 2017-09-26 | 2020-09-04 | 宾夕法尼亚大学理事会 | 用于抑制acss2的组合物和方法 |
| CA2984073A1 (en) | 2017-10-27 | 2019-04-27 | Nuchem Therapeutics Inc. | Inhibitors of polynucleotide repeat-associated rna foci and uses thereof |
| EP3710430B9 (en) | 2017-11-15 | 2024-10-30 | Metabomed Ltd | Acss2 inhibitors and methods of use thereof |
| EP3983386A4 (en) | 2019-05-14 | 2023-01-11 | Metabomed Ltd | ACSS2 INHIBITORS AND METHODS OF USE THEREOF |
-
2020
- 2020-05-14 EP EP20806829.6A patent/EP3983386A4/en not_active Withdrawn
- 2020-05-14 CA CA3136083A patent/CA3136083A1/en active Pending
- 2020-05-14 JP JP2021567836A patent/JP2022532718A/ja active Pending
- 2020-05-14 AU AU2020273727A patent/AU2020273727A1/en not_active Abandoned
- 2020-05-14 EP EP20805317.3A patent/EP3969439A4/en not_active Withdrawn
- 2020-05-14 CN CN202080045626.8A patent/CN114008025A/zh active Pending
- 2020-05-14 CA CA3136324A patent/CA3136324A1/en active Pending
- 2020-05-14 MX MX2021013786A patent/MX2021013786A/es unknown
- 2020-05-14 AU AU2020274645A patent/AU2020274645A1/en not_active Abandoned
- 2020-05-14 KR KR1020217040740A patent/KR20220024014A/ko not_active Ceased
- 2020-05-14 WO PCT/IL2020/050524 patent/WO2020230134A1/en not_active Ceased
- 2020-05-14 SG SG11202112277PA patent/SG11202112277PA/en unknown
- 2020-05-14 SG SG11202112226WA patent/SG11202112226WA/en unknown
- 2020-05-14 CN CN202080050593.6A patent/CN114127049A/zh active Pending
- 2020-05-14 BR BR112021022977A patent/BR112021022977A2/pt not_active IP Right Cessation
- 2020-05-14 US US17/609,392 patent/US12441689B2/en active Active
- 2020-05-14 MX MX2021013839A patent/MX2021013839A/es unknown
- 2020-05-14 JP JP2021567839A patent/JP2022532719A/ja active Pending
- 2020-05-14 BR BR112021023030A patent/BR112021023030A2/pt not_active Application Discontinuation
- 2020-05-14 KR KR1020217040841A patent/KR20220024027A/ko not_active Withdrawn
- 2020-05-14 WO PCT/IL2020/050526 patent/WO2020230136A1/en not_active Ceased
-
2021
- 2021-05-12 CA CA3176666A patent/CA3176666A1/en active Pending
- 2021-05-12 KR KR1020227043156A patent/KR20230012522A/ko active Pending
- 2021-05-12 EP EP21803230.8A patent/EP4149928A4/en active Pending
- 2021-05-12 IL IL297883A patent/IL297883A/en unknown
- 2021-05-12 MX MX2022014214A patent/MX2022014214A/es unknown
- 2021-05-12 JP JP2022568774A patent/JP7723011B2/ja active Active
- 2021-05-12 US US17/922,795 patent/US20230174507A1/en active Pending
- 2021-05-12 WO PCT/IL2021/050541 patent/WO2021229571A1/en not_active Ceased
- 2021-05-12 AU AU2021273125A patent/AU2021273125A1/en active Pending
- 2021-05-12 CN CN202180038652.2A patent/CN115697974A/zh active Pending
- 2021-11-08 IL IL287937A patent/IL287937A/en unknown
- 2021-11-09 IL IL287973A patent/IL287973A/en unknown
-
2025
- 2025-07-31 JP JP2025128256A patent/JP7904373B2/ja active Active
- 2025-09-08 US US19/321,644 patent/US20260085048A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL297883A (en) | acss2 inhibitors based on imidazole 3-oxide derivatives and methods for their use | |
| RU2095356C1 (ru) | Способ получения производных таксана и производные таксана | |
| IL274504B2 (en) | Acss2 inhibitors and methods of use thereof | |
| JP7811768B2 (ja) | ピロール化合物 | |
| JP2011509309A5 (cg-RX-API-DMAC7.html) | ||
| JPH02212435A (ja) | 哺乳動物における内毒素シヨツクの治療方法 | |
| JP2007508238A5 (cg-RX-API-DMAC7.html) | ||
| RU2002117422A (ru) | 4-пиримидинил-N-ацил-L-фенилаланины | |
| JP2017534657A (ja) | 新型シチジン誘導体およびその適用 | |
| JP2002529465A5 (cg-RX-API-DMAC7.html) | ||
| EP2123620A1 (en) | {F-19}-labeled L-Glutamic acid and L-Glutamine derivative (III), use thereof and method for obtaining them | |
| JP2018526448A (ja) | 一酸化窒素を放出可能なプロドラッグ分子 | |
| EP2669280B1 (en) | Bicyclic compound and use thereof for medical purposes | |
| JP2022546711A5 (cg-RX-API-DMAC7.html) | ||
| ES2945062T3 (es) | Derivados de ácido barbitúrico novedosos, su preparación y uso de los mismos como inhibidores de la transmigración de leucocitos y para el tratamiento de enfermedades inflamatorias, enfermedades autoinmunitarias y cáncer | |
| US12473305B2 (en) | Pyrazole boronic acid compound, pharmaceutical composition containing same, and uses thereof | |
| JP2017137323A (ja) | 新規抗がん剤 | |
| JP2021532158A5 (cg-RX-API-DMAC7.html) | ||
| JP2026503618A5 (cg-RX-API-DMAC7.html) | ||
| JP2020518649A5 (cg-RX-API-DMAC7.html) | ||
| RU2011129771A (ru) | Противораковые соединения | |
| JP2022523792A5 (cg-RX-API-DMAC7.html) | ||
| RU2025115630A (ru) | Производные тиадиазолила в качестве ингибиторов днк-полимеразы тета и их применение | |
| US5599825A (en) | Water-soluble methine compound and pharmaceutical composition for treatment of cancer comprising the same | |
| JP6542799B2 (ja) | 新規peg誘導体 |